Nuclear Cardiology: 2014 Innovations and Developments

Mahmarian, John J.; Chang, SuMin; Nabi, Faisal

doi:10.14797/mdcj-10-3-163

Cited by 5 publications

(2 citation statements)

References 47 publications

(44 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…7 The studies show that F-18 flurpiridaz with PET myocardial imaging had higher sensitivity and similar specificity than the patients undergoing invasive angiography. 31 F-18 flurpiridaz may provide an important development in current noninvasive imaging of CAD based on its favorable dosimetry, linear extraction across MBF, improved spatial resolution and longer half-life. 31 …”

Section: Future Pet Radiopharmaceuticalmentioning

confidence: 99%

See 1 more Smart Citation

Current status of myocardial perfusion imaging radiopharmaceuticals for SPECT and PET imaging modalities

2016

View full text Add to dashboard Cite

Coronary artery disease (CAD) is the leading cause of death and remains a major health problem worldwide. Myocardial perfusion imaging (MPI) with single photon emission tomography (SPECT) and positron emission tomography (PET) has been established as the main functional nuclear cardiology noninvasive technique for CAD over the past years. The studies has been shown that the use of MPI as a useful and important imaging modality for the diagnosis, risk stratification and treatment planning for CAD. The purpose of this article is to review properties of the radiopharmaceuticals used for myocardial perfusion imaging with SPECT and PET.

show abstract

Section: Future Pet Radiopharmaceuticalmentioning

confidence: 99%

“…31 F-18 flurpiridaz may provide an important development in current noninvasive imaging of CAD based on its favorable dosimetry, linear extraction across MBF, improved spatial resolution and longer half-life. 31 …”

Section: Future Pet Radiopharmaceuticalmentioning

confidence: 99%

Current status of myocardial perfusion imaging radiopharmaceuticals for SPECT and PET imaging modalities

2016

View full text Add to dashboard Cite

show abstract

Diagnostic Imaging in European Eastern Countries: a Russian Experience

Намазова-Баранова

Баранов

Смирнов

et al. 2016

Clinical Nuclear Medicine in Pediatrics

View full text Add to dashboard Cite

Perfusion Scintigraphy of the Myocardium in Various Forms of Cardiac Pathology in Children

Komarova

Сиденко

Смирнов

et al. 2019

jour

View full text Add to dashboard Cite

Perfusion scintigraphy of the myocardium was carried out with the help of the Millennium MG gamma camera (USA) in synchronization with the ECG in 141 patients aged of from 5 to 15 years. Patients were divided into four groups: 30 chronic myocarditis (CM) patients, 30 hypertrophic cardiomyopathy (HCMP) patients, 30 dilated cardiomyopathy (DCMP) cases and 21noncompact cardiomyopathy (NCMP) patients. The left ventricular (LV) ejection fraction was established to be preserved in CM and HCMC patients (in cases without signs of obstruction), a significant reduction in the ejection fraction was found in NKMP and DCMP patients. The thickness of the myocardium of the LV significantly increased only in HCM patients. The expansion of the LV cavity was detected in all patients, but its decrease was present only in HCM cases. The contractility of the myocardium was impaired in all the patients examined. Disturbances of the myocardial perfusion were the most pronounced in NKMP and DCMP patients. Signs of fibrosis were detected in most patients, but HCM patients. In 40% of CM patients, scintigraphic signs of inflammation were determined. In 17% of all examinations there was noted hyperperfusion of the right ventricular myocardium. The authors believe myocardial tomoscintigraphy to be the unique method for analyzing myocardial viability in various forms of cardiac pathology that can be used for the evaluation of the effectiveness of the treatment.

show abstract

Nuclear Cardiology: 2014 Innovations and Developments

Cited by 5 publications

References 47 publications

Current status of myocardial perfusion imaging radiopharmaceuticals for SPECT and PET imaging modalities

Current status of myocardial perfusion imaging radiopharmaceuticals for SPECT and PET imaging modalities

Diagnostic Imaging in European Eastern Countries: a Russian Experience

Perfusion Scintigraphy of the Myocardium in Various Forms of Cardiac Pathology in Children

Contact Info

Product

Resources

About